Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug:129:104541.
doi: 10.1016/j.jcv.2020.104541. Epub 2020 Jul 6.

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens

Affiliations

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens

Pauline Trémeaux et al. J Clin Virol. 2020 Aug.

Abstract

Background: The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which appeared in late 2019, has been limited by isolating infected individuals. However, identifying such individuals requires accurate diagnostic tools.

Objective: This study evaluates the capacity of the Aptima™ Transcription-Mediated Amplification (TMA) assay (Hologic® Panther System) to detect the virus in clinical samples.

Study design: We compared the Aptima™ assay to two in-house real-time RT-PCR techniques, one running on the Panther Fusion™ module and the other on the MagNA Pure 96 and Light-Cycler 480 instruments. We included a total of 200 respiratory specimens: 100 tested prospectively and 100 retrospectively (25 -ve/75 +ve).

Results: The final Cohen's kappa coefficients were: κ = 0.978 between the Aptima™ and Panther Fusion™ assays, κ = 0.945 between the Aptima™ and MagNA/LC480 assays and κ = 0.956 between the MagNA/LC480 and Panther Fusion™ assays.

Conclusion: These findings indicate that the Aptima™ SARS-CoV-2 TMA assay data agree well with those obtained with our routine methods and that this assay can be used to diagnose coronavirus disease 2019 (COVID-19).

Keywords: COVID-19; Coronavirus; Hologic® Panther System; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None declared.

Similar articles

Cited by

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W. China Novel Coronavirus Investigating and Research Team. 2020. A novel coronavirus from patients with pneumonia in China. N. Eng. J. Med. 2019;382:727–733. - PMC - PubMed
    1. World Heanlth Organisation . 2020. 01 June 2020 2020. Coronavirus (COVID-19) Situation Report - 133.https://www.who.int/docs/default-source/coronaviruse/situation-reports/ Accessed 01 June 2020.
    1. Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K., Bleicker T., Brunink S., Schneider J., Schmidt M.L., Mulders D.G., Haagmans B.L., van der Veer B., van den Brink S., Wijsman L., Goderski G., Romette J.L., Ellis J., Zambon M., Peiris M., Goossens H., Reusken C., Koopmans M.P., Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25 - PMC - PubMed
    1. World Heanlth Organisation . 2020. 24 January 2020 2020. Molecular Assays to Diagnose COVID-19: Summary Table of Available Protocols.https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pd... Accessed 10 February 2020.
    1. Tang Y.W., Schmitz J.E., Persing D.H., Stratton C.W. Laboratory diagnosis of COVID-19: current issues and challenges. J. Clin. Microbiol. 2020;58 - PMC - PubMed

Publication types

MeSH terms